牛熊異動 | 盈利超預期,融創購漲超90%!
港股融創中國今天重越50天、20天、10天及牛熊線(30.74-32.55元),最高見33.7元。截至發稿,融創中國漲9.09%,報33港元,融創法巴一七購A漲超90%。
【通過日內融買入1手融創中國,僅需佔用本金3300港元】
消息面上,融創中國全年多賺37%末期息按年年增34%至1.65元。融創公佈,去年純利按年增長37%至356.44億元人民幣(下同),每股基本盈利7.82元,末期股息按年增34%至1.65元。期內,毛利按年增長16.9%至484億元;核心淨利潤按年增長11.8%至302.6億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.